Literature DB >> 12811735

Learning networks in health and Parkinson's disease: reproducibility and treatment effects.

Maren Carbon1, Maria Felice Ghilardi, Andrew Feigin, Masafumi Fukuda, Giulia Silvestri, Marc J Mentis, Claude Ghez, James R Moeller, David Eidelberg.   

Abstract

In a previous H(2) (15)O/PET study of motor sequence learning, we used principal components analysis (PCA) of region of interest (ROI) data to identify performance-related activation patterns in normal subjects and patients with Parkinson's disease (PD). In the present study, we determined whether these patterns predicted learning performance in subsequent normal and untreated PD cohorts. Using a voxel-based PCA approach, we correlated the changes in network activity that occurred during antiparkinsonian treatment and their relationship to learning performance. We found that the previously identified ROI-based patterns correlated with learning performance in the prospective normal (P < 0.01) and untreated PD (P < 0.05) cohorts. Voxel analysis revealed that target retrieval was related to a network characterized by bilateral activation of the dorsolateral prefrontal, premotor and anterior cingulate cortex, the precuneus, and the occipital association areas as well as the right ventral prefrontal and inferior parietal regions. Target acquisition was associated with a different network involving activation of the caudate, putamen, and right dentate nucleus, as well as the left ventral prefrontal and inferior parietal areas. Antiparkinsonian therapy gave rise to changes in retrieval performance that correlated with network modulation (P < 0.01). Increases in network activation and learning performance occurred with internal pallidal deep brain stimulation (GPi DBS); decrements in these measures were present with levodopa. Our findings suggest that network analysis of activation data can provide stable descriptors of learning performance. Network quantification can provide an objective means of assessing the effects of therapy on cognitive functioning in neurodegenerative disorders. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12811735      PMCID: PMC6871830          DOI: 10.1002/hbm.10115

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  71 in total

1.  Individual differences in PET activation of object perception and attention systems predict face matching accuracy.

Authors:  G E Alexander; M J Mentis; J D Van Horn; C L Grady; K F Berman; M L Furey; P Pietrini; S I Rapoport; M B Schapiro; J R Moeller
Journal:  Neuroreport       Date:  1999-06-23       Impact factor: 1.837

2.  Functional correlates of pallidal stimulation for Parkinson's disease.

Authors:  M Fukuda; M Mentis; M F Ghilardi; V Dhawan; A Antonini; J Hammerstad; A M Lozano; A Lang; K Lyons; W Koller; C Ghez; D Eidelberg
Journal:  Ann Neurol       Date:  2001-02       Impact factor: 10.422

3.  Changes in brain activity related to eating chocolate: from pleasure to aversion.

Authors:  D M Small; R J Zatorre; A Dagher; A C Evans; M Jones-Gotman
Journal:  Brain       Date:  2001-09       Impact factor: 13.501

4.  Transition of brain activation from frontal to parietal areas in visuomotor sequence learning.

Authors:  K Sakai; O Hikosaka; S Miyauchi; R Takino; Y Sasaki; B Pütz
Journal:  J Neurosci       Date:  1998-03-01       Impact factor: 6.167

5.  Organization of corticostriatal and corticoamygdalar projections arising from the anterior inferotemporal area TE of the macaque monkey: a Phaseolus vulgaris leucoagglutinin study.

Authors:  K Cheng; K S Saleem; K Tanaka
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

6.  Spatial and non-spatial working memory at different stages of Parkinson's disease.

Authors:  A M Owen; J L Iddon; J R Hodges; B A Summers; T W Robbins
Journal:  Neuropsychologia       Date:  1997-04       Impact factor: 3.139

7.  The metabolic topography of normal aging.

Authors:  J R Moeller; T Ishikawa; V Dhawan; P Spetsieris; F Mandel; G E Alexander; C Grady; P Pietrini; D Eidelberg
Journal:  J Cereb Blood Flow Metab       Date:  1996-05       Impact factor: 6.200

8.  Influence of chronic bilateral stimulation of the subthalamic nucleus on cognitive function in Parkinson's disease.

Authors:  K Dujardin; L Defebvre; P Krystkowiak; S Blond; A Destée
Journal:  J Neurol       Date:  2001-07       Impact factor: 4.849

9.  Dopaminergic modulation of cortical function in patients with Parkinson's disease.

Authors:  Venkata S Mattay; Alessandro Tessitore; Joseph H Callicott; Alessandro Bertolino; Terry E Goldberg; Thomas N Chase; Thomas M Hyde; Daniel R Weinberger
Journal:  Ann Neurol       Date:  2002-02       Impact factor: 10.422

10.  Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study.

Authors:  E D Playford; I H Jenkins; R E Passingham; J Nutt; R S Frackowiak; D J Brooks
Journal:  Ann Neurol       Date:  1992-08       Impact factor: 10.422

View more
  31 in total

1.  Metabolic brain networks associated with cognitive function in Parkinson's disease.

Authors:  Chaorui Huang; Paul Mattis; Chengke Tang; Kenneth Perrine; Maren Carbon; David Eidelberg
Journal:  Neuroimage       Date:  2006-11-17       Impact factor: 6.556

Review 2.  The assessment of neurological systems with functional imaging.

Authors:  David Eidelberg
Journal:  Brain Lang       Date:  2006-08-08       Impact factor: 2.381

3.  Network modulation in the treatment of Parkinson's disease.

Authors:  Kotaro Asanuma; Chengke Tang; Yilong Ma; Vijay Dhawan; Paul Mattis; Christine Edwards; Michael G Kaplitt; Andrew Feigin; David Eidelberg
Journal:  Brain       Date:  2006-07-14       Impact factor: 13.501

4.  Assessment of disease progression in parkinsonism.

Authors:  Kotaro Asanuma; Vijay Dhawan; Maren Carbon; David Eidelberg
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

5.  Increased cerebellar activation during sequence learning in DYT1 carriers: an equiperformance study.

Authors:  Maren Carbon; Maria Felice Ghilardi; Miklos Argyelan; Vijay Dhawan; Susan B Bressman; David Eidelberg
Journal:  Brain       Date:  2007-10-18       Impact factor: 13.501

Review 6.  Dopamine overdose hypothesis: evidence and clinical implications.

Authors:  David E Vaillancourt; Daniel Schonfeld; Youngbin Kwak; Nicolaas I Bohnen; Rachael Seidler
Journal:  Mov Disord       Date:  2013-10-09       Impact factor: 10.338

Review 7.  The many facets of motor learning and their relevance for Parkinson's disease.

Authors:  Lucio Marinelli; Angelo Quartarone; Mark Hallett; Giuseppe Frazzitta; Maria Felice Ghilardi
Journal:  Clin Neurophysiol       Date:  2017-04-09       Impact factor: 3.708

8.  Changes in network activity with the progression of Parkinson's disease.

Authors:  Chaorui Huang; Chengke Tang; Andrew Feigin; Martin Lesser; Yilong Ma; Michael Pourfar; Vijay Dhawan; David Eidelberg
Journal:  Brain       Date:  2007-04-30       Impact factor: 13.501

9.  Abnormal regional brain function in Parkinson's disease: truth or fiction?

Authors:  Yilong Ma; Chengke Tang; James R Moeller; David Eidelberg
Journal:  Neuroimage       Date:  2008-10-18       Impact factor: 6.556

10.  Early Parkinson's disease: longitudinal changes in brain activity during sequence learning.

Authors:  Maren Carbon; Kathrin Reetz; M Felice Ghilardi; Vijay Dhawan; David Eidelberg
Journal:  Neurobiol Dis       Date:  2009-11-10       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.